Fundraising Fox

Auxilium Biotechnologies

San Diego, US · Founded 2019 · Delaware corporation

Auxilium Biotechnologies develops regenerative medicine devices, including the NeuroSpan Bridge, an implantable device to aid peripheral nerve regeneration. The company also works on in-space biomanufacturing, having demonstrated 3D bioprinting of implantable medical devices in microgravity aboard the ISS.

Founders & leadership

YK
Yacov KofflerNamed on SEC filing
DC
Donald CohnNamed on SEC filing

Board

CA
Craig AndrewsBoard director
MT
Mark TuszynskiBoard director
RE
Robert EnglerBoard director

Reported raises · per SEC filings

Form D private placements

$7.2M disclosed across 2 rounds · 2020–2025

$3.9MraisedDec 2025 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yacov KofflerExecutive Officer, Director
  • Craig AndrewsDirector
  • Mark TuszynskiDirector
  • Robert EnglerDirector
Offering amount
$10M
Amount sold
$3.9M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.2MraisedJan 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert EnglerDirector
  • Craig AndrewsDirector
  • Yacov KofflerExecutive Officer, Director
  • Mark TuszynskiDirector
  • Donald CohnDirector
Offering amount
$4M
Amount sold
$3.2M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Auxilium Biotechnologies do?
Auxilium Biotechnologies develops regenerative medicine devices, including the NeuroSpan Bridge, an implantable device to aid peripheral nerve regeneration. The company also works on in-space biomanufacturing, having demonstrated 3D bioprinting of implantable medical devices in microgravity aboard the ISS.
How much funding has Auxilium Biotechnologies raised?
Auxilium Biotechnologies has disclosed $7.2M raised across 2 rounds.
Where is Auxilium Biotechnologies headquartered?
Auxilium Biotechnologies is headquartered in San Diego, US.